NCT01357837 - Assessment of GRT6005 in Painful Osteoarthritis of the Knee | Biotech Hunter

Enrollment

207

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

Matching Placebo

2 capsules of matching placebo once a day, in the morning, for a total of 28 days

DRUG

GRT6005

2 capsules containing a total of 75 µg GRT6005 once a day, in the morning, for a total of 28 days

DRUG

GRT6005

2 capsules containing a total of 200 µg GRT6005 once a day, in the morning, for a total of 28 days

DRUG

GRT6005

2 capsules containing a total of 400 µg GRT6005 once a day, in the morning, for a total of 28 days

Trial Locations (26)

1090

Site 3603, Vienna

1100

Site 3602, Vienna

1130

Site 3601, Vienna

3541

Site 3605, Senftenberg

4021

Site 3604, Linz

15006

Site 3303, A Coruña

15705

Site 3304, Santiago de Compostela

29009

Site 3312, Málaga

33009

Site 3310, Oviedo

39300

Site 3313, Torrelavega

41009

Site 3306, Seville

15-337

Site 3203, Bialystok

82-300

Site 3202, Elblag

81-834

Site 3208, Gdynia

30-349

Site 3206, Krakow

20-605

Site 3207, Lublin

71-252

Site 3210, Szczecin

87-100

Site 3201, Torun

02-730

Site 3211, Warsaw

Unknown

Site 3204, Warsaw

50-088

Site 3205, Wroclaw

29-100

Site 3213, Włoszczowa

08028

Site 3305, Barcelona

08034

Site 3302, Barcelona

06800

Site 3308, Mérida

03610

Site 3311, Petrel